Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Kidney Medullary Sodium Content Using 23Na MRI to Understand and Predict Diuretic Resistance
NCT04170855Active, not recruiting
- Start
- Oct 2020
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of furosemide in cardiorenal syndrome (CRS). Primary endpoint: Medullary sodium concentration at 60 minutes. Started Oct 2020; status: active, not recruiting.
02
Drugs
furosemide
03
Conditions
cardiorenal syndrome (CRS)
Beyond the preview
Go deeper on NCT04170855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170855.